Stardots AB — Biomedical Watch V2

Traitements3programmes

Essais1liés

Publications0liées

SourceDBlocale

Traitements

3

Molécule	Indication / population	Phase	Objectif	Pays	Résultat
150% of their routine home dopaminergic medications dose right in the clinicThis is a three-armed open investigational study that aims to differentiate, quantify, and categorize abnormal eye movements and upper limbs movements in patients with Parkinson's disease. The study is using investigational non-invasive devices for that reason including ANLIVA® Hand Movement and ANLIVA® Eye Movement.	Parkinson	Non applicable	À vérifier	United States	À vérifier
Evaluation of mathematical modelsThis is a three-armed open investigational study that aims to differentiate, quantify, and categorize abnormal eye movements and upper limbs movements in patients with Parkinson's disease. The study is using investigational non-invasive devices for that reason including ANLIVA® Hand Movement and ANLIVA® Eye Movement.	Parkinson	Non applicable	À vérifier	United States	À vérifier
150% of their routine home dopaminergic medications dose right in the clinicThis is a three-armed open investigational study that aims to differentiate, quantify, and categorize abnormal eye movements and upper limbs movements in patients with Parkinson's disease. The study is using investigational non-invasive devices for that reason including ANLIVA® Hand Movement and ANLIVA® Eye Movement.	Parkinson	Non applicable	À vérifier	United States	À vérifier

Essais cliniques

1

Molécule	Indication / population	Phase	NCT	Titre	Statut
150% of their routine home dopaminergic medications dose right in the clinic	Parkinson	Non applicable	NCT06586320	Quantification of Parkinson's Disease Patients as a Biomarker for Classification, Prediction and Response to Treatment	ENROLLING_BY_INVITATION

Publications

0

Molécule	Indication / population	Titre	Journal	Date
Aucune publication.